Working with Professor Francesca Taraballi, the manager of the Center for Musculoskeletal Regeneration, Dr. Assaf Zinger is specifically trying to target: atherosclerosis plaque to remedy coronary disease; glial cells to find a cure for glioblastoma, a deadly brain cancer; and human neurons to treat RETT syndrome, a rare postnatal disorder.

Dr. Zinger received his Technion bachelor’s degree in biomedical engineering and went on to receive his master’s and doctoral degrees at the Faculty of Chemical Engineering in Assistant Prof. Avi Schroeder’s Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies. One of their many outstanding achievements entailed combining enzymes with nanoscale drug delivery systems to perform localized procedures that would have otherwise required surgery, in a more effective and noninvasive manner. Dr. Zinger also worked on a new device for treating pancreatic cancer based on the slow release of drugs.

The grandson of a Holocaust survivor, Dr. Zinger served the Israel Defense Forces (IDF) during three wars and operations: the so-called Second Lebanon War (2006), in which he received the armored brigade excellency award for his role as Operations Officer of the 188 Brigade; Operation Pillar of Defense (2012) and Operation Protective Edge (2014). As a reservist, he serves as the Executive Officer of the Armored Corps Headquarters. He currently lives in Houston with his wife, Noa, an occupational therapist working with autistic and deaf children and manager of the “Gvanim” program at the Israeli-American Council, and their daughters Ayala and Tamara.

View Events

See past or upcoming events featuring this speaker.

Splash Statement

STAY INFORMED

Learn how the Technion is powering Israel and changing the world.

Sign-Up